These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 35055244)
21. Rational application of nanoadjuvant for mucosal vaccine delivery system. Dewangan HK J Immunol Methods; 2020; 481-482():112791. PubMed ID: 32387695 [TBL] [Abstract][Full Text] [Related]
22. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines. Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120 [TBL] [Abstract][Full Text] [Related]
23. Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways. Li M; Zhao M; Fu Y; Li Y; Gong T; Zhang Z; Sun X J Control Release; 2016 Apr; 228():9-19. PubMed ID: 26941035 [TBL] [Abstract][Full Text] [Related]
32. Strategies to Develop a Mucosa-Targeting Vaccine against Emerging Infectious Diseases. Feng F; Wen Z; Chen J; Yuan Y; Wang C; Sun C Viruses; 2022 Mar; 14(3):. PubMed ID: 35336927 [TBL] [Abstract][Full Text] [Related]
33. Delivery strategies to enhance oral vaccination against enteric infections. Davitt CJ; Lavelle EC Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337 [TBL] [Abstract][Full Text] [Related]
34. Toll-like Receptor-4 (TLR4) Agonist-Based Intranasal Nanovaccine Delivery System for Inducing Systemic and Mucosal Immunity. Bakkari MA; Valiveti CK; Kaushik RS; Tummala H Mol Pharm; 2021 Jun; 18(6):2233-2241. PubMed ID: 34010002 [TBL] [Abstract][Full Text] [Related]
35. New generation of mucosal adjuvants for the induction of protective immunity. Yuki Y; Kiyono H Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340 [TBL] [Abstract][Full Text] [Related]